Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.18 AUD | +12.50% | -2.70% | 0.00% |
Apr. 23 | Microba's Revenue Climbs 297% in Fiscal Q3 | MT |
Apr. 10 | Microba Life Sciences Secures AU$6 Million Tax Rebate for Fiscal Year 2023; Shares Fall 5% | MT |
Chart calendar Microba Life Sciences Limited
Upcoming events on Microba Life Sciences Limited
Past events on Microba Life Sciences Limited
2024-04-22 10:00 pm | March 2024 Sales and Revenue Call - Activities Report |
2024-04-22 07:04 pm | March 2024 Sales and Revenue Release - Activities Report |
2024-02-27 05:02 pm | Q2 2024 Earnings Release |
2024-01-29 | December 2023 Sales and Revenue Call - Activities Report |
2024-01-29 05:11 pm | December 2023 Sales and Revenue Release - Activities Report |
2023-11-29 08:00 pm | Annual General Meeting |
2023-11-15 08:00 pm | Bell Potter Healthcare Conference |
2023-11-09 | Investor Meeting - Day 5 |
2023-11-08 | Investor Meeting - Day 4 |
2023-11-07 | Investor Meeting - Day 3 |
2023-11-06 | Investor Meeting - Day 2 |
2023-11-05 | Investor Meeting - Day 1 |
2023-10-18 08:30 pm | Acquisition of Invivo Clinical Ltd by Microba Life Sciences Ltd Call |
2023-10-18 05:52 pm | September 2023 Sales and Revenue Release - Activities Report |
2023-08-29 07:15 pm | Q4 2023 Earnings Release |
2023-08-03 12:00 am | TechKnow Invest Conference |
2023-07-26 08:30 pm | June 2023 Sales and Revenue Call - Activities Report |
2023-07-26 07:04 pm | June 2023 Sales and Revenue Release - Activities Report |
2023-04-19 08:30 pm | March 2023 Sales and Revenue Call - Activities Report |
2023-04-19 07:05 pm | March 2023 Sales and Revenue Release - Activities Report |
Annual results
Fiscal Period | June | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,00 | 4,69 4,65 0.83% | 5,42 4,95 9.5% | 11,8 |
EBITDA Million AUD | Released Forecast Spread | 0,00 | -9,86 -11,9 17.12% | -11,0 -12,1 9.32% | -16,9 |
EBIT Million AUD | Released Forecast Spread | 0,00 | -11,4 -13,4 14.56% | -12,6 -13,9 9.25% | -18,5 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | 0,00 | -11,5 -13,5 14.79% | -12,7 -13,6 6.46% | -17,3 |
Net income Million AUD | Released Forecast Spread | -7,52 | -11,5 -13,5 14.72% | -12,7 -13,6 6.42% | -17,3 |
EPS AUD | Released Forecast Spread | -0,04 | -0,05 -0,05 5.69% | -0,04 -0,04 9.44% | -0,04 |
Announcement Date | 01/04/22 | 25/08/22 | 29/08/23 | - |
Quarterly results
Fiscal Period | June | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 2,49 2,50 -0.41% | 2,15 3,00 -28.28% | 3,27 4,40 -25.62% | 8,60 | |
EBITDA Million AUD | Released Forecast Spread | -4,54 -6,30 27.87% | -10,9 -6,60 -65.75% | -7,30 | ||
EBIT Million AUD | Released Forecast Spread | -5,40 -7,40 27% | -5,79 -3,60 -60.97% | |||
Net income Million AUD | Released Forecast Spread | -5,44 -7,30 25.48% | -5,68 -3,50 -62.26% | -7,00 -6,50 -7.71% | -7,80 | |
Announcement Date | 25/08/22 | 22/02/23 | 29/08/23 | 27/02/24 | - |
2024-04-28 | SMO CLINPLUS CO.,LTD.: Q4 2023 Earnings Release |
2024-04-29 | NEOGENOMICS, INC.: Q1 2024 Earnings Release |
2024-05-03 07:00 am | FULGENT GENETICS, INC.: Q1 2024 Earnings Release |
2024-05-05 | OPKO HEALTH, INC.: Q1 2024 Earnings Release (Projected) |
2024-05-07 | RADNET, INC.: Q1 2024 Earnings Release |
2024-05-07 | SYNLAB AG: Q1 2024 Earnings Release |
2024-05-08 | FLEURY S.A.: Q1 2024 Earnings Release |
2024-05-09 | H.U. GROUP HOLDINGS, INC.: Q4 2023 Earnings Release |
2024-05-09 | BML, INC.: Q4 2023 Earnings Release |
2024-05-09 | GC CELL CORPORATION: Q1 2024 Earnings Release (Projected) |
Past sector events for Microba Life Sciences Limited
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MAP Stock
- Calendar Microba Life Sciences Limited